Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunologic safety study of Alphanate in previously treated patients with severe hemophilia A
2006-002635-24Phase 4Completed
- Sponsor
- Grifols
- Start
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of von Willebrand factor human in hemophilia A, sponsored by Grifols. Primary endpoint: Incidence of factor VIII inhibitor after exposure to Alphanate. Started Dec 2008; status: completed.
02
Drugs
von Willebrand factor human
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2006-002635-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002635-24.